Domain EYEION.com for sale! This premium domain is available now at Kadomain.com

Largest review of antidepressants to date finds most people do not experience severe withdrawal

  • medicalxpress.com language
  • 2025-07-09 22:03 event
  • 1 week ago schedule
Largest review of antidepressants to date finds most people do not experience severe withdrawal
The largest review of "gold standard" antidepressant withdrawal studies to date has identified the type and incidence of symptoms experienced by people discontinuing antidepressants, finding most people do not experience severe withdrawal.

476. New tool measures fairness in NYC hospital care

  • 1 week ago schedule
  • medicalxpress.com language

A new study from CUNY SPH researchers puts forth a straightforward way to measure whether hospitals are providing fair access to care for low-income and uninsured patients.

477. Updated guidelines improve throat cancer staging

  • 1 week ago schedule
  • medicalxpress.com language

Cedars-Sinai investigators led an update of staging guidelines for HPV-positive throat cancer—now more common in the U.S. than cervical cancer, according to the American Cancer Society—that will make treatment of early-stage disease more consistent and appropriate. Their study was published in The Lancet Oncology.

478. High glucose levels in people with diabetes linked to tripling of eye disease risk

  • 1 week ago schedule
  • medicalxpress.com language

Older people with diabetes who do not keep blood sugar levels low are three times more likely to develop eye disease compared to counterparts who have reduced blood sugar levels, suggests a new study by a UCL team.

479. Tirzepatide reduces food intake and appetite, and affects brain functioning, more than placebo and liraglutide

  • 1 week ago schedule
  • medicalxpress.com language

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight, food intake and many measures of appetite more than placebo and liraglutide. These results were recently published in Nature Medicine in the study titled "Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial."

480. Barbie's latest look? It includes an insulin pump and glucose monitor

  • 1 week ago schedule
  • medicalxpress.com language

Barbie's latest look includes a polka-dot crop top, chunky heels—and an insulin pump.

481. Novel T-cell subtypes in follicular lymphoma linked to patient prognosis

  • 1 week ago schedule
  • medicalxpress.com language

Researchers at University of Tsukuba have identified multiple T-cell subtypes with unique characteristics in follicular lymphoma, a prevalent type of blood cancer. These T cells regulate the proliferation and apoptosis of tumor cells and significantly affect patient prognosis. This discovery, published in Cancer Cell, is anticipated to enhance the understanding of malignant lymphoma and improve clinical management strategies.

482. Experimental compound offers potential treatment for rare, often fatal childhood disease

  • 1 week ago schedule
  • medicalxpress.com language

The value of a recent biochemical discovery can be seen in the case of an 8-year-old boy who was playing typical sports in August 2023, but by November needed a wheelchair because of a rare disease that caused worsening paralysis.

483. ADHD in children: How to maintain family balance

  • 1 week ago schedule
  • medicalxpress.com language

Attention deficit disorder, with or without hyperactivity (ADHD), can be a problem outside of school because it disrupts the quality of life of families. Between stigmatization, chronic stress and feelings of helplessness, many families feel overwhelmed by this still poorly understood disorder.

484. Gut microbes may hold key to understanding how exercise boosts cancer immunotherapy response

  • 1 week ago schedule
  • medicalxpress.com language

A new study from the University of Pittsburgh shows for the first time how exercise improves cancer outcomes and enhances response to immunotherapy in mice by reshaping the gut microbiome.

485. Largest review of antidepressants to date finds most people do not experience severe withdrawal

  • 1 week ago schedule
  • medicalxpress.com language

The largest review of "gold standard" antidepressant withdrawal studies to date has identified the type and incidence of symptoms experienced by people discontinuing antidepressants, finding most people do not experience severe withdrawal.

486. New compound may help the brain heal itself after injury

  • 1 week ago schedule
  • medicalxpress.com language

Researchers from the University of Georgia found a new drug that may boost the brain's ability to heal itself after injury. The discovery could lead to significant advances in treating traumatic brain injuries, or TBIs.

487. Live dance performance syncs brainwaves, study suggests

  • 1 week ago schedule
  • medicalxpress.com language

A study published in iScience suggests that the magic of live performance art may be reflected in our brains. When people watched a live contemporary dance performance, their brainwaves synced up, signaling shared focus and attention—but that synchrony didn't occur when people watched the same performance alone on video.

488. Weight loss clears out aging cells and boosts lipid recycling, study finds

  • 1 week ago schedule
  • medicalxpress.com language

Scientists have produced the first detailed characterization of the changes that weight loss causes in human fat tissue by analyzing hundreds of thousands of cells. They found a range of positive effects, including clearing out of damaged, aging cells, and increased metabolism of harmful fats.

489. Cooling garments can protect laborers in a hotter world

  • 1 week ago schedule
  • medicalxpress.com language

The world is getting hotter and hotter: 2024 was the hottest year on record, and 2025 is on track to come in a close second.

490. Clinical trials reveal promising alternatives to high-toxicity tuberculosis drug

  • 1 week ago schedule
  • medicalxpress.com language

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with the potential to replace this current cornerstone in the treatment of drug-resistant TB.

491. Ice baths are booming in popularity—but they come with health risks

  • 1 week ago schedule
  • medicalxpress.com language

Walk through any trendy suburb and you might find a new "wellness" studio offering ice baths or "contrast therapy" (a sauna and ice bath combo).

492. What kind of plastic surgery did Kylie Jenner have? She'll tell you, and it may not be a good thing, expert says

  • 1 week ago schedule
  • medicalxpress.com language

Have you ever wondered what kind of cosmetic surgeries the Kardashians and Jenners have had? They'll go one further and tell you not only what they had done, but why and who did it.

493. Fight to understand myalgic encephalomyelitis takes a major step forward

  • 1 week ago schedule
  • medicalxpress.com language

Being asked to produce a book by an international publishing giant was an exciting milestone for Emeritus Professor Warren Tate—one that recognized a decades-long crusade to get recognition for a debilitating illness.

494. Study shows more support needed for police mental health

  • 1 week ago schedule
  • medicalxpress.com language

Child abuse, murder, domestic violence. A glance at newspaper headlines is enough to highlight the challenging situations faced by police officers daily.

Cookie Policy

We use cookies and similar technologies to help the site provide a better user experience. By using the website you agree to our Cookie Policy, Terms of Use and Privacy Policy.